423 related articles for article (PubMed ID: 16493840)
21. Biotechnology products and university-based science.
Sobolski GK
JAMA; 2005 Jun; 293(23):2862; author reply 2863. PubMed ID: 15956629
[No Abstract] [Full Text] [Related]
22. Biotechnology patents and ethical aspects.
Terragni F
Cancer Detect Prev; 1993; 17(2):317-21. PubMed ID: 8402719
[TBL] [Abstract][Full Text] [Related]
23. In pursuit of patents: 21st century challenges.
Blatt RJ
J Biolaw Bus; 1998; 1(4):4-7. PubMed ID: 11657745
[No Abstract] [Full Text] [Related]
24. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
25. Patenting transgenics in the European Union.
Baggot B
Nat Biotechnol; 1998 Mar; 16(3):299-301. PubMed ID: 9528013
[No Abstract] [Full Text] [Related]
26. Intellectual property rights. Public sector collaboration for agricultural IP management.
Atkinson RC; Beachy RN; Conway G; Cordova FA; Fox MA; Holbrook KA; Klessig DF; McCormick RL; McPherson PM; Rawlings HR; Rapson R; Vanderhoef LN; Wiley JD; Young CE
Science; 2003 Jul; 301(5630):174-5. PubMed ID: 12855794
[No Abstract] [Full Text] [Related]
27. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
Trask AV
Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
[No Abstract] [Full Text] [Related]
28. The distribution of biomedical research resources and international justice.
Resnik DB
Dev World Bioeth; 2004 May; 4(1):42-57. PubMed ID: 15086373
[TBL] [Abstract][Full Text] [Related]
29. Biotech patents-business as usual?
Lawrence S
Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
[No Abstract] [Full Text] [Related]
30. Biotechnology: a challenge for Hippocrates.
Huynen S
Auckl Univ Law Rev; 1991; 6(4):534-51. PubMed ID: 16127862
[No Abstract] [Full Text] [Related]
31. Biotechnology products and university-based science.
Korn D; Heinig SJ
JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
[No Abstract] [Full Text] [Related]
32. Patents, biomedical research, and treatments: examining concerns, canvassing solutions.
Johnston J; Wasunna AA;
Hastings Cent Rep; 2007; 37(1):S1-36. PubMed ID: 17348259
[No Abstract] [Full Text] [Related]
33. Wrong map: why public science can't really be public.
Mukherjee S
New Repub; 2000 May; 222(19):14-5. PubMed ID: 12465651
[No Abstract] [Full Text] [Related]
34. Agricultural IP and the public sector.
Huete-Pérez JA
Science; 2003 Oct; 302(5646):781-3; author reply 781-3. PubMed ID: 14593149
[No Abstract] [Full Text] [Related]
35. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
36. Ethical aspects of patenting in biotechnology.
Crespi RS
Cancer Detect Prev; 1993; 17(2):323-7. PubMed ID: 8402720
[No Abstract] [Full Text] [Related]
37. Gold in the ivory tower: equity rewards of outlicensing.
Edwards M; Murray F; Yu R
Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129
[TBL] [Abstract][Full Text] [Related]
38. Intellectual property and biotechnology: the U.S. internal experience--Part II.
Brody B
Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
[TBL] [Abstract][Full Text] [Related]
39. The role of the private sector in biotechnology: research and development.
Feisee L
Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
[No Abstract] [Full Text] [Related]
40. Should the patent system for new medicines be abolished?
DiMasi JA; Grabowski HG
Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
